[Cafergot compound (suppositories) in therapy of migraine & Horton's syndrome].
D002110:Caffeine / Q000627:therapeutic use*; D002317:Cardiovascular Agents; D003027:Cluster Headache; D004338:Drug Combinations; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D004878:Ergotamine; D006261:Headache / Q000628:therapy*; D008881:Migraine Disorders / Q000628:therapy*; D013488:Suppositories
D002317:Cardiovascular Agents; D004338:Drug Combinations; D004876:Ergot Alkaloids; D013488:Suppositories; C037330:caffeine, ergotamine drug combination; D002110:Caffeine; D004878:Ergotamine
CAFFEINE/therapeutic use; ERGOT ALKALOIDS/therapeutic use; HEADACHE/therapy; MIGRAINE/therapy
Behandling av migrän och Hortons syndrom med cafergot comp. (stolpiller).